Related references
Note: Only part of the references are listed.Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine
Irina Daurkin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
Carmela De Santo et al.
NATURE IMMUNOLOGY (2010)
Modulators of arginine metabolism support cancer immunosurveillance
Giusy Capuano et al.
BMC IMMUNOLOGY (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
Hyun-Jeong Ko et al.
JOURNAL OF IMMUNOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Mononuclear myeloid-derived suppressor cells express RAE-1 and activate natural killer cells
Norman Nausch et al.
BLOOD (2008)
Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
Gourapura J. Renukaradhya et al.
BLOOD (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Reversal of Myeloid Cell - Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Sergei Kusmartsev et al.
CLINICAL CANCER RESEARCH (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
α-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity
Yeon-Jeong Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tumor-induced CD11b(+)Gr-1(+) myeloid cells suppress T cell Sensitization in tumor-draining lymph nodes
Satoshi Watanabe et al.
JOURNAL OF IMMUNOLOGY (2008)
NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis
Jay A. Berzofsky et al.
JOURNAL OF IMMUNOLOGY (2008)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis
Masaki Terabe et al.
TRENDS IN IMMUNOLOGY (2007)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Hyun-Jeong Ko et al.
CANCER RESEARCH (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo
Yeonseok Chung et al.
CANCER RESEARCH (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Generation and maturation of dendritic cells for clinical application under serum-free conditions
JC Peng et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants
SY Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells
DI Gabrilovich et al.
JOURNAL OF IMMUNOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
SA Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
